The results of this obesity medication are literally eye-popping. A new review of adverse effects reports to the FDA between ...

Wegovy, a GLP-1 agonist for weight loss, may carry the highest risk of "eye stroke" (ischemic optic neuropathy) and sudden sight loss of the semaglutide drugs, finds an analysis of unintended side ...

Eye strokes’ that reduce blood flow to optic nerve likely to be side-effect of active ingredient semaglutide, says author ...

Todd Engel, a resident of Columbia, Md., is among the dozens of Americans now suing the maker of the popular diabetes and weight-loss drug Ozempic after they say the medication led to vision loss.

NAION is often referred to as an ‘eye stroke’, it causes sudden, painless vision loss - usually in one eye, but sometimes in both eyes.

Share on Pinterest Researchers believe that high doses of semaglutide may reduce blood flow to the optic nerve, which could lead to eye stroke. Maria Korneeva/Getty Images A new study has found that ...

NAION (Non-Arteritic Anterior Ischemic Optic Neuropathy) officially describes vision loss caused by reduced blood flow to the optic nerve ...

Ozempic blindness isn’t a real diagnosis. It’s a nickname used to describe sudden vision loss that may be linked to the weight loss drugs semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, ...

The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare eye condition known as NAION (non-arteritic anterior ischemic optic ...

Glucagon-like peptide-1 receptor agonist drugs (commonly referred to as GLP-1 agonists) have become widely prescribed for type 2 diabetes and weight loss. Medications such as Ozempic, Wegovy, Mounjaro ...

Weight loss jab ‘may carry higher risk of sudden sight loss’ as new warning issued - Wegovy is approved on the NHS to help people lose weight in higher doses ...